Bharat Biotech Covid-19 vaccine phase-2 trial to begin in PGI Rohtak Medical Dialogues Bureau10 Sept 2020 10:15 AM IST"In India, Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR is in the Phase II trial along with Zydus Cadila's candidate...
Russian COVID vaccine Sputnik V induces antibody response in small human trials Medical Dialogues Bureau5 Sept 2020 11:36 AM ISTThese vaccines aim to stimulate both arms of the immune system -- antibody and T cell responses -- so they attack the virus when it is circulating in...
Bharat Biotech, Zydus Cadila COVID-19 vaccine in phase 2 trial, says VK Paul Medical Dialogues Bureau1 Sept 2020 10:15 AM ISTNew Delhi: Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two...
French drugmaker Sanofi more confident about its COVID vaccines: Report Farhat Nasim31 Aug 2020 9:45 AM IST“Our confidence has increased. We have work to do like everybody on manufacturing in large volumes. But we will have one, maybe two vaccines next...
Govt amends CSR norms to allow pharma firms to contribute to COVID-19 RnD; Details Farhat Nasim27 Aug 2020 5:43 PM ISTNew Delhi: Through a recent Gazette notification, the Government has amended the Companies Corporate Social Responsibility Policy (CSR) Rules, 2014 to...
Bharat Biotech gets CDSCO green flag to conduct Covaxin trial via Intradermal route Farhat Nasim24 Aug 2020 2:19 PM ISTNew Delhi: In a major advancement, Hyderabad-based drugmaker Bharat Biotech has secured permission from Central Drugs Standard Control Organisation...
COVID-19 Vaccine candidates progressing well, working to ramp up capacity with facilitations: Dr VK Paul Medical Dialogues Bureau20 Aug 2020 9:00 AM ISTNew Delhi - More than 3 crore tests conducted so far, while 8,99,864 tests, which is the highest number of tests in a single day, have been conducted...
Oxford-AstraZeneca Covid-19 vaccine gets ICMR nod to begin trials at KEM, Nair hospitals Farhat Nasim19 Aug 2020 4:10 PM ISTMumbai: The Oxford University-Astra Zeneca Covid-19 vaccine, Covishield will undergo Phase 2 and Phase 3 clinical trials by August-end at two...
COVID-19 warriors will first ones to get vaccine dose, announces MoS Health Medical Dialogues Bureau19 Aug 2020 9:15 AM ISTNew Delhi - Scientists are working hard on coronavirus vaccine and if their efforts bear fruit, COVID-19 warriors will be the first ones to get the...
Serum Institute to offer up to 100 million doses of COVID vaccine priced at less than Rs 250 per dose Farhat Nasim8 Aug 2020 11:15 AM ISTNew Delhi: The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose...
AIIMS, PGI Chandigarh among 17 trial sites for conducting human trials of COVID vaccine by Oxford MD Bureau4 Aug 2020 12:45 PM ISTIn addition to PGI Chandigarh, the other sites for trials include: AIIMS in Delhi, ABJ Medical College in Pune, Rajendra Memorial Research Institute...
Pfizer-BioNTech potential COVID vaccine shows promise in second early trial Medical Dialogues Bureau1 Aug 2020 9:45 AM ISTNew York: German biotech BioNTech and U.S. drugmaker Pfizer Inc recently said data from an early-stage trial of their experimental coronavirus vaccine...
